This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 2001;106(3):141-2.

doi: 10.1159/000046607.

Rituximab in combination with interferon-alpha in relapsed and refractory diffuse large B-cell non-Hodgkin's lymphoma

R Bertè¹, D Vallisa, G Civardi, C F Moroni, A Lazzaro, L Cavanna

Affiliations

PMID: 11713384
DOI: 10.1159/000046607

Case Reports

Rituximab in combination with interferon-alpha in relapsed and refractory diffuse large B-cell non-Hodgkin's lymphoma

R Bertè et al. Acta Haematol. 2001.

. 2001;106(3):141-2.

doi: 10.1159/000046607.

Authors

R Bertè¹, D Vallisa, G Civardi, C F Moroni, A Lazzaro, L Cavanna

Affiliation

¹ Department of Internal Medicine, Hematology and Oncology Program, Hospital of Piacenza, Italy.

PMID: 11713384
DOI: 10.1159/000046607

No abstract available

PubMed Disclaimer

Similar articles

Rituximab in heavily pretreated cutaneous B-cell lymphoma.
Zinzani PL, Stefoni V, Alinari L, Vianelli N, Baccarani M. Zinzani PL, et al. Leuk Lymphoma. 2003 Sep;44(9):1637-8. doi: 10.3109/10428190309178793. Leuk Lymphoma. 2003. PMID: 14565673 No abstract available.
Rituximab combined with MACOP-B or VACOP-B and radiation therapy in primary mediastinal large B-cell lymphoma: a retrospective study.
Zinzani PL, Stefoni V, Finolezzi E, Brusamolino E, Cabras MG, Chiappella A, Salvi F, Rossi A, Broccoli A, Martelli M. Zinzani PL, et al. Clin Lymphoma Myeloma. 2009 Oct;9(5):381-5. doi: 10.3816/CLM.2009.n.074. Clin Lymphoma Myeloma. 2009. PMID: 19858058
[Treatment strategy of gray zone lymphomas].
Maruyama D. Maruyama D. Rinsho Ketsueki. 2014 Oct;55(10):1912-9. Rinsho Ketsueki. 2014. PMID: 25297755 Review. Japanese. No abstract available.
Effect of combination chemotherapy with cefoperazone on non-Hodgkin's lymphoma.
Natazuka T, Matsui T, Ito M, Sugimoto T, Nakao Y, Fujita T. Natazuka T, et al. Leuk Res. 1992;16(4):417-8. doi: 10.1016/0145-2126(92)90146-x. Leuk Res. 1992. PMID: 1373460 No abstract available.
HIV-related lymphoma treated with maintenance thalidomide.
Larson ML, Enschede SH, Gregory SA. Larson ML, et al. Clin Adv Hematol Oncol. 2005 Mar;3(3):231-4; discussion 234-5. Clin Adv Hematol Oncol. 2005. PMID: 16166993 Review. No abstract available.

See all similar articles

Cited by

Toll-like Receptor 4 Ligands Down-regulate Fcγ Receptor IIb (FcγRIIb) via MARCH3 Protein-mediated Ubiquitination.
Fatehchand K, Ren L, Elavazhagan S, Fang H, Mo X, Vasilakos JP, Dietsch GN, Hershberg RM, Tridandapani S, Butchar JP. Fatehchand K, et al. J Biol Chem. 2016 Feb 19;291(8):3895-904. doi: 10.1074/jbc.M115.701151. Epub 2015 Dec 22. J Biol Chem. 2016. PMID: 26694610 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Supplementary concepts

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- S. Karger AG, Basel, Switzerland